[go: up one dir, main page]

KR950700725A - 리포솜 조성물(liposome composition) - Google Patents

리포솜 조성물(liposome composition)

Info

Publication number
KR950700725A
KR950700725A KR1019940703508A KR19940703508A KR950700725A KR 950700725 A KR950700725 A KR 950700725A KR 1019940703508 A KR1019940703508 A KR 1019940703508A KR 19940703508 A KR19940703508 A KR 19940703508A KR 950700725 A KR950700725 A KR 950700725A
Authority
KR
South Korea
Prior art keywords
composition
liposome
liposomal
peyer
glands
Prior art date
Application number
KR1019940703508A
Other languages
English (en)
Other versions
KR100217826B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700725A publication Critical patent/KR950700725A/ko
Application granted granted Critical
Publication of KR100217826B1 publication Critical patent/KR100217826B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940703508A 1992-04-10 1993-04-09 리포솜조성물 KR100217826B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11802592 1992-04-10
JP92-118025 1992-04-10
PCT/JP1993/000460 WO1993020801A1 (en) 1992-04-10 1993-04-09 Liposome composition

Publications (2)

Publication Number Publication Date
KR950700725A true KR950700725A (ko) 1995-02-20
KR100217826B1 KR100217826B1 (ko) 1999-09-01

Family

ID=14726206

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703508A KR100217826B1 (ko) 1992-04-10 1993-04-09 리포솜조성물

Country Status (8)

Country Link
US (1) US5573779A (ko)
EP (1) EP0728476B1 (ko)
KR (1) KR100217826B1 (ko)
AT (1) ATE223204T1 (ko)
AU (1) AU668934B2 (ko)
CA (1) CA2117769C (ko)
DE (1) DE69332276T2 (ko)
WO (1) WO1993020801A1 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
HUP9801834A3 (en) 1995-10-12 2000-06-28 Supergen Inc Emeryville Liposome formulations of 5beta steroids
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
AU682805B1 (en) * 1996-03-22 1997-10-16 Biosphere Technologies Inc. Method for inducing a systemic immune response to an antigen
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US6207185B1 (en) * 1996-03-22 2001-03-27 Bio-Sphere Technology Method for inducing a systemic immune response to an HIV antigen
US20020136762A1 (en) * 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
AU4574199A (en) * 1998-06-16 2000-01-05 Jackie R. See Method for introducing a chemical agent into the systemic circulation
US6828306B2 (en) * 2000-07-31 2004-12-07 Ottawa Heart Institute Research Corporation Charged lipid compositions and methods for their use
FR2836043B1 (fr) * 2002-02-15 2004-06-04 Inst Nat Sante Rech Med Vesicules lipidiques, preparation et utilisations
US7875288B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
CA2660310C (en) * 2006-03-30 2015-04-21 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
US20090081284A1 (en) * 2006-04-20 2009-03-26 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
CN102727437A (zh) * 2006-08-02 2012-10-17 牛津大学院长校长专家委员会 病毒感染的脂质体治疗
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2410989A2 (en) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Cholesterol level lowering liposomes
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
WO2013070362A1 (en) * 2011-10-06 2013-05-16 The Research Foundation Of State University Of New York Compositions and methods for immune tolerance induction
WO2013148258A1 (en) 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
FR3119325B1 (fr) * 2021-01-29 2023-08-11 Renault Jean Yves Compositions liposomales orales

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645444A1 (de) * 1976-10-08 1978-04-13 Karl Dr Med Theurer Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
EP0432693A1 (en) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Liposomes cytotoxic to virus-infected cells
JPH03236325A (ja) * 1989-12-11 1991-10-22 Sumitomo Chem Co Ltd ウイルス感染細胞を殺傷するリポソーム
EP0640347A1 (en) * 1992-03-03 1995-03-01 Daiichi Pharmaceutical Co., Ltd. Oral vaccine

Also Published As

Publication number Publication date
AU668934B2 (en) 1996-05-23
EP0728476A1 (en) 1996-08-28
US5573779A (en) 1996-11-12
EP0728476B1 (en) 2002-09-04
DE69332276T2 (de) 2003-01-09
KR100217826B1 (ko) 1999-09-01
CA2117769C (en) 2003-07-22
WO1993020801A1 (en) 1993-10-28
AU3904193A (en) 1993-11-18
ATE223204T1 (de) 2002-09-15
EP0728476A4 (en) 1997-09-10
CA2117769A1 (en) 1993-10-11
DE69332276D1 (de) 2002-10-10

Similar Documents

Publication Publication Date Title
KR950700725A (ko) 리포솜 조성물(liposome composition)
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ATE65392T1 (de) In mizellulare phospholipidische partikel eingekapselte antineoplastische anthracyclinmittel.
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
DE58905028D1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
AU4711296A (en) Method for loading lipid vesicles
IT1203577B (it) Composti lipidici anfifili procedimento per la loro preparazione e loro applicazioni particolarmente in cosmesi e dermatologia
NZ503568A (en) Biphasic lipid vesicle composition for transdermal administration of an immunogen
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
PL334940A1 (en) Lipoid complexes and liposomes of highly insoluble platinum complexes
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
DK0613685T3 (da) Liposomer, indeholdende chlorhexidindiacetat eller chlorhexidindigluconat
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
AU4934485A (en) Solid drug formulations and stable suspensions
GR3029581T3 (en) Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
FR2619505B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
ATE199315T1 (de) Liposomzubereitungen enthaltend hybrid-interferon
RU94027343A (ru) Липосомальная везикула с цитохромом с

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 19941005

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19941005

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19981014

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990331

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990607

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990608

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020311

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20030328

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20030328

Start annual number: 5

End annual number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20050311